Of all the diseases and illnesses that afflict human populations, tuberculosis is one that has had significant historical impact, but presently lies outside most people's concern. But new work suggests just how much impact TB may have had on the European population, appearing to leave a footprint in the genome that accounts for a high level of cystic fibrosis mutations.
Cystic fibrosis is the most common lethal single-gene mutation in people of European descent, with a carrier frequency upwards of 2 per cent. Based upon molecular research, resistances in the heterozygote to cholera and typhoid fever have been proposed to explain the persistence of the mutation. Using a population genetic model parameterised with historical demographic and epidemiological data, Eric Poolman and Alison Galvani at Yale University show in a paper in the Journal of the Royal Society Interface (published online), that neither cholera nor
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New research suggests that the significance of TB for the prevalence of cystic fibrosis mutations in European populations may have been overlooked as fears grow over the threat from aggressive new drug-resistant strains. Nigel Williams reports.
Footprint fears for new TB threat
typhoid fever provided enough historical selective pressure to produce the modern incidence of cystic fibrosis.
However, the authors show that the European tuberculosis pandemic beginning in the seventeenth century would have provided sufficient historical, geographically appropriate selective pressure under conservative assumptions.
Tuberculosis has been underappreciated as a possible selective agent in producing cystic fibrosis but has clinical, molecular and now historical, geographical and epidemiological support.
And last month, world health officials put out an unprecedented warning that deadly new strains of tuberculosis, virtually untreatable using the drugs currently available, appear to be spreading across the globe, raising the spectre of a resurgence in a disease which for many generations has laid in the background, seemingly beaten, but which may now make a major comeback as a lethal new pathogen.
The new strains are known as extreme drug-resistant TB or XDR-TB. They have been identified and have killed people in several countries, including the US and Eastern Europe, and they have recently been found in Africa, where they could swiftly put an end to all hope of containing the Aids pandemic through treatment.
Paul Nunn, head of the WHO's TB resistance team, said the situation was very serious. There are nine million cases of TB in the world and the WHO estimates that two per cent of them -or 180,000 -could be XDR-TB. "This is raising the spectre of something that we have worried might happen for a decade -the possibility of virtually untreatable TB," he said.
Even in the US, which has the best medicines available, a third of those diagnosed with XDR-TB have died. In March, the Centers for Disease Control registered 64 cases in the US; 21 of those ended in death.
Significant numbers of cases have been confirmed in Latvia and Russia, but in many parts of the world XDR-TB could be present but unrecognised. One of the reasons the WHO is concerned is that tuberculosis spreads easily in confined spaces, such as aircraft. Multi-drug resistant TB strains -those that are resistant to the two basic, first-line drugs used to treat the disease -have spread everywhere, including to the UK. Multi-drug resistant TB is increasingly common and difficult and expensive to treat. The patient must be given four out of the six existing second-line drugs. But the XDR-TB strains now appearing seem resistant to at least three out of those six second-line drugs and there are no third-line drugs.
The spectre of a new outbreak of untreatable TB has been raised because of the identification of a cluster of cases in KwaZulu-Natal, South Africa. Researchers studied 544 TB patients and found 221 had strains against which the two common drugs had no effect. They further found that 53 of the patients had XDR-TB, and 52 of them died within an average of 25 days. All these patients were HIV-positive, so the occurrence of XDR-TB may have major implications for anti-viral treatments.
While the situation in South Africa has heightened global concern about the new TB strains, any leads that may generate new approaches to therapy are urgently sought.
Poolman and Galvani hope their work may lead to one new avenue. Resistance to tuberculosis in cystic fibrosis patients was recently considered to arise from diminished activity of the enzyme arylsulphatase B. The tuberculosis bacilli lack intrinsic arylsulphatase activity, but they have an arylsulphotransferase that may require sulphate from the host to construct their cell walls. Cell wall sulphate content has been correlated with virulence, so dysfunction of host arylsulphatase activity in cystic fibrosis may help protect against TB by depriving the bacteria of a necessary nutrient, write Poolman and Galvani. "Our result supports the importance of novel investigations into the role of arylsulphatase B deficiency in cystic fibrosis and tuberculosis," they say.
With South African researchers working desperately to contain the outbreak there, any new leads are welcome.
Their work highlights the impact of tuberculosis in the past in Europe. "Tuberculosis combines ancient endemicity with a recent epidemic of European origin and severe mortality, particularly among young adults at the peak of their reproductive potential. Consequently, tuberculosis would provide sufficient selective pressure in the correct parts of the world," their study suggests. The newly drug-resistant disease's more global current occurrence is cause for future concern.
Blooming alarm
Residents of the remote north-east Indian state of Mizoram are currently facing an almost only once-in-a-lifetime show: the spectacular flowering of native bamboo, which occurs only once every 47-48 years. But rather than relishing the sight, the locals are full of dread for folklore has it that the flowers are a harbinger of famine. And this is not mere superstition, but soundly based in fact.
Bamboo species are remarkable for their varying periodicities of flowering -from annually to once only every 120 years -and the synchronisation of flowering within one species in one area. Some species show quite distinct periodicities at different geographical locations. But the outcome of these mass flowerings is the same: the production of vast amounts of protein-rich seeds. And it is the gorging on these seeds by the local rat populations which then explode in size, that is the cause of worry for Mizoram's people.
When the seed supply dries up the huge rat population turns to human crops and stores in search of food.
Although the main blossoming of the local bamboo is not expected until next year, in some regions there are already reports of rats invading paddy crops and granaries. "Countless numbers of rats raided paddy crops in two villages during night-time, while there were reports of a moderate rat invasion coming from other areas of the state," said James Laisiamiliana, a Mizoram government agricultural scientist, last month.
